Algert Global’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Algert Global's LLY Position: Q1 2026 in Review
Algert Global increased its Eli Lilly (LLY) stake by 5.1% in Q1 2026, buying an estimated $777K and bringing the position to 15,642 shares worth $14.4M. The position accounts for 0.22% of the portfolio, ranked #127.
Algert Global first reported a position in LLY in Q4 2013 and has held it in 16 quarters since. The position peaked at $16M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Algert Global held 15,642 shares of Eli Lilly worth $14.4M as of Q1 2026.
- Algert Global bought 766 Eli Lilly shares in Q1 2026, an estimated $777K.
- Eli Lilly made up 0.22% of Algert Global's portfolio in Q1 2026, its #127 holding.
- Algert Global first reported a position in Eli Lilly in Q4 2013 and has held it in 16 quarters since.
- Algert Global's Eli Lilly position peaked at $16M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.